The company continued to discuss possible equity investments/partnerships from other strategic investors and has obtained a commitment for additional funding should it need over the coming 12 months in the absence of other fund raising.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025